Global Ropivacaine Hydrochloride Injection Market Growth 2020-2025
According to this study, over the next five years the Ropivacaine Hydrochloride Injection market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Ropivacaine Hydrochloride Injection business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Ropivacaine Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Ropivacaine Hydrochloride Injection, covering the supply chain analysis, impact assessment to the Ropivacaine Hydrochloride Injection market size growth rate in several scenarios, and the measures to be undertaken by Ropivacaine Hydrochloride Injection companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
2 Mg/ml
5 Mg/ml
7.5 Mg/ml
10 Mg/ml
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Surgical Anesthesia
Acute Pain Management
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Fresenius Kabi
Nephron Pharmaceuticals
Sintetica
Akorn
Zhuhai Yipin Pharmaceutical Group
Chengdu Tiantaishan Pharmaceutical
Qilu Pharmaceutical
Haisco Pharmaceutical Group
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Ropivacaine Hydrochloride Injection consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Ropivacaine Hydrochloride Injection market by identifying its various subsegments.
Focuses on the key global Ropivacaine Hydrochloride Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ropivacaine Hydrochloride Injection with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Ropivacaine Hydrochloride Injection submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ropivacaine Hydrochloride Injection Consumption 2015-2025
2.1.2 Ropivacaine Hydrochloride Injection Consumption CAGR by Region
2.2 Ropivacaine Hydrochloride Injection Segment by Type
2.2.1 2 Mg/ml
2.2.2 5 Mg/ml
2.2.3 7.5 Mg/ml
2.2.4 10 Mg/ml
2.3 Ropivacaine Hydrochloride Injection Consumption by Type
2.3.1 Global Ropivacaine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
2.3.2 Global Ropivacaine Hydrochloride Injection Revenue and Market Share by Type (2015-2020)
2.3.3 Global Ropivacaine Hydrochloride Injection Sale Price by Type (2015-2020)
2.4 Ropivacaine Hydrochloride Injection Segment by Application
2.4.1 Surgical Anesthesia
2.4.2 Acute Pain Management
2.4.3 Other
2.5 Ropivacaine Hydrochloride Injection Consumption by Application
2.5.1 Global Ropivacaine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
2.5.2 Global Ropivacaine Hydrochloride Injection Value and Market Share by Type (2015-2020)
2.5.3 Global Ropivacaine Hydrochloride Injection Sale Price by Type (2015-2020)
3 Global Ropivacaine Hydrochloride Injection by Company
3.1 Global Ropivacaine Hydrochloride Injection Sales Market Share by Company
3.1.1 Global Ropivacaine Hydrochloride Injection Sales by Company (2018-2020)
3.1.2 Global Ropivacaine Hydrochloride Injection Sales Market Share by Company (2018-2020)
3.2 Global Ropivacaine Hydrochloride Injection Revenue Market Share by Company
3.2.1 Global Ropivacaine Hydrochloride Injection Revenue by Company (2018-2020)
3.2.2 Global Ropivacaine Hydrochloride Injection Revenue Market Share by Company (2018-2020)
3.3 Global Ropivacaine Hydrochloride Injection Sale Price by Company
3.4 Global Ropivacaine Hydrochloride Injection Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Ropivacaine Hydrochloride Injection Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Ropivacaine Hydrochloride Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Ropivacaine Hydrochloride Injection by Regions
4.1 Ropivacaine Hydrochloride Injection by Regions
4.2 Americas Ropivacaine Hydrochloride Injection Consumption Growth
4.3 APAC Ropivacaine Hydrochloride Injection Consumption Growth
4.4 Europe Ropivacaine Hydrochloride Injection Consumption Growth
4.5 Middle East & Africa Ropivacaine Hydrochloride Injection Consumption Growth
5 Americas
5.1 Americas Ropivacaine Hydrochloride Injection Consumption by Countries
5.1.1 Americas Ropivacaine Hydrochloride Injection Consumption by Countries (2015-2020)
5.1.2 Americas Ropivacaine Hydrochloride Injection Value by Countries (2015-2020)
5.2 Americas Ropivacaine Hydrochloride Injection Consumption by Type
5.3 Americas Ropivacaine Hydrochloride Injection Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Ropivacaine Hydrochloride Injection Consumption by Regions
6.1.1 APAC Ropivacaine Hydrochloride Injection Consumption by Regions (2015-2020)
6.1.2 APAC Ropivacaine Hydrochloride Injection Value by Regions (2015-2020)
6.2 APAC Ropivacaine Hydrochloride Injection Consumption by Type
6.3 APAC Ropivacaine Hydrochloride Injection Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Ropivacaine Hydrochloride Injection by Countries
7.1.1 Europe Ropivacaine Hydrochloride Injection Consumption by Countries (2015-2020)
7.1.2 Europe Ropivacaine Hydrochloride Injection Value by Countries (2015-2020)
7.2 Europe Ropivacaine Hydrochloride Injection Consumption by Type
7.3 Europe Ropivacaine Hydrochloride Injection Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Ropivacaine Hydrochloride Injection by Countries
8.1.1 Middle East & Africa Ropivacaine Hydrochloride Injection Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Ropivacaine Hydrochloride Injection Value by Countries (2015-2020)
8.2 Middle East & Africa Ropivacaine Hydrochloride Injection Consumption by Type
8.3 Middle East & Africa Ropivacaine Hydrochloride Injection Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Ropivacaine Hydrochloride Injection Distributors
10.3 Ropivacaine Hydrochloride Injection Customer
11 Global Ropivacaine Hydrochloride Injection Market Forecast
11.1 Global Ropivacaine Hydrochloride Injection Consumption Forecast (2021-2025)
11.2 Global Ropivacaine Hydrochloride Injection Forecast by Regions
11.2.1 Global Ropivacaine Hydrochloride Injection Forecast by Regions (2021-2025)
11.2.2 Global Ropivacaine Hydrochloride Injection Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Ropivacaine Hydrochloride Injection Forecast by Type
11.8 Global Ropivacaine Hydrochloride Injection Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Ropivacaine Hydrochloride Injection Product Offered
12.1.3 Pfizer Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Fresenius Kabi
12.2.1 Company Information
12.2.2 Ropivacaine Hydrochloride Injection Product Offered
12.2.3 Fresenius Kabi Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Fresenius Kabi Latest Developments
12.3 Nephron Pharmaceuticals
12.3.1 Company Information
12.3.2 Ropivacaine Hydrochloride Injection Product Offered
12.3.3 Nephron Pharmaceuticals Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Nephron Pharmaceuticals Latest Developments
12.4 Sintetica
12.4.1 Company Information
12.4.2 Ropivacaine Hydrochloride Injection Product Offered
12.4.3 Sintetica Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sintetica Latest Developments
12.5 Akorn
12.5.1 Company Information
12.5.2 Ropivacaine Hydrochloride Injection Product Offered
12.5.3 Akorn Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Akorn Latest Developments
12.6 Zhuhai Yipin Pharmaceutical Group
12.6.1 Company Information
12.6.2 Ropivacaine Hydrochloride Injection Product Offered
12.6.3 Zhuhai Yipin Pharmaceutical Group Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zhuhai Yipin Pharmaceutical Group Latest Developments
12.7 Chengdu Tiantaishan Pharmaceutical
12.7.1 Company Information
12.7.2 Ropivacaine Hydrochloride Injection Product Offered
12.7.3 Chengdu Tiantaishan Pharmaceutical Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Chengdu Tiantaishan Pharmaceutical Latest Developments
12.8 Qilu Pharmaceutical
12.8.1 Company Information
12.8.2 Ropivacaine Hydrochloride Injection Product Offered
12.8.3 Qilu Pharmaceutical Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Qilu Pharmaceutical Latest Developments
12.9 Haisco Pharmaceutical Group
12.9.1 Company Information
12.9.2 Ropivacaine Hydrochloride Injection Product Offered
12.9.3 Haisco Pharmaceutical Group Ropivacaine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Haisco Pharmaceutical Group Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Ropivacaine Hydrochloride Injection Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 2 Mg/ml
Table 5. Major Players of 5 Mg/ml
Table 6. Major Players of 7.5 Mg/ml
Table 7. Major Players of 10 Mg/ml
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Ropivacaine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 10. Global Ropivacaine Hydrochloride Injection Revenue by Type (2015-2020) ($ million)
Table 11. Global Ropivacaine Hydrochloride Injection Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Ropivacaine Hydrochloride Injection Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Ropivacaine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 15. Global Ropivacaine Hydrochloride Injection Value by Application (2015-2020)
Table 16. Global Ropivacaine Hydrochloride Injection Value Market Share by Application (2015-2020)
Table 17. Global Ropivacaine Hydrochloride Injection Sale Price by Application (2015-2020)
Table 18. Global Ropivacaine Hydrochloride Injection Sales by Company (2017-2019) (MT)
Table 19. Global Ropivacaine Hydrochloride Injection Sales Market Share by Company (2017-2019)
Table 20. Global Ropivacaine Hydrochloride Injection Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Ropivacaine Hydrochloride Injection Revenue Market Share by Company (2017-2019)
Table 22. Global Ropivacaine Hydrochloride Injection Sale Price by Company (2017-2019)
Table 23. Global Ropivacaine Hydrochloride Injection Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Ropivacaine Hydrochloride Injection Products Offered
Table 25. Ropivacaine Hydrochloride Injection Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Ropivacaine Hydrochloride Injection Consumption by Regions 2015-2020 (MT)
Table 27. Global Ropivacaine Hydrochloride Injection Consumption Market Share by Regions 2015-2020
Table 28. Global Ropivacaine Hydrochloride Injection Value by Regions 2015-2020 ($ Millions)
Table 29. Global Ropivacaine Hydrochloride Injection Value Market Share by Regions 2015-2020
Table 30. Americas Ropivacaine Hydrochloride Injection Consumption by Countries (2015-2020) (MT)
Table 31. Americas Ropivacaine Hydrochloride Injection Consumption Market Share by Countries (2015-2020)
Table 32. Americas Ropivacaine Hydrochloride Injection Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Ropivacaine Hydrochloride Injection Value Market Share by Countries (2015-2020)
Table 34. Americas Ropivacaine Hydrochloride Injection Consumption by Type (2015-2020) (MT)
Table 35. Americas Ropivacaine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 36. Americas Ropivacaine Hydrochloride Injection Consumption by Application (2015-2020) (MT)
Table 37. Americas Ropivacaine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 38. APAC Ropivacaine Hydrochloride Injection Consumption by Countries (2015-2020) (MT)
Table 39. APAC Ropivacaine Hydrochloride Injection Consumption Market Share by Countries (2015-2020)
Table 40. APAC Ropivacaine Hydrochloride Injection Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Ropivacaine Hydrochloride Injection Value Market Share by Regions (2015-2020)
Table 42. APAC Ropivacaine Hydrochloride Injection Consumption by Type (2015-2020) (MT)
Table 43. APAC Ropivacaine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 44. APAC Ropivacaine Hydrochloride Injection Consumption by Application (2015-2020) (MT)
Table 45. APAC Ropivacaine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 46. Europe Ropivacaine Hydrochloride Injection Consumption by Countries (2015-2020) (MT)
Table 47. Europe Ropivacaine Hydrochloride Injection Consumption Market Share by Countries (2015-2020)
Table 48. Europe Ropivacaine Hydrochloride Injection Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Ropivacaine Hydrochloride Injection Value Market Share by Countries (2015-2020)
Table 50. Europe Ropivacaine Hydrochloride Injection Consumption by Type (2015-2020) (MT)
Table 51. Europe Ropivacaine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 52. Europe Ropivacaine Hydrochloride Injection Consumption by Application (2015-2020) (MT)
Table 53. Europe Ropivacaine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption by Countries (2015-2020) (MT)
Table 55. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Ropivacaine Hydrochloride Injection Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Ropivacaine Hydrochloride Injection Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption by Type (2015-2020) (MT)
Table 59. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption by Application (2015-2020) (MT)
Table 61. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 62. Ropivacaine Hydrochloride Injection Distributors List
Table 63. Ropivacaine Hydrochloride Injection Customer List
Table 64. Global Ropivacaine Hydrochloride Injection Consumption Forecast by Countries (2021-2025) (MT)
Table 65. Global Ropivacaine Hydrochloride Injection Consumption Market Forecast by Regions
Table 66. Global Ropivacaine Hydrochloride Injection Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Ropivacaine Hydrochloride Injection Value Market Share Forecast by Regions
Table 68. Global Ropivacaine Hydrochloride Injection Consumption Forecast by Type (2021-2025) (MT)
Table 69. Global Ropivacaine Hydrochloride Injection Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Ropivacaine Hydrochloride Injection Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Ropivacaine Hydrochloride Injection Value Market Share Forecast by Type (2021-2025)
Table 72. Global Ropivacaine Hydrochloride Injection Consumption Forecast by Application (2021-2025) (MT)
Table 73. Global Ropivacaine Hydrochloride Injection Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Ropivacaine Hydrochloride Injection Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Ropivacaine Hydrochloride Injection Value Market Share Forecast by Application (2021-2025)
Table 76. Pfizer Product Offered
Table 77. Pfizer Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Pfizer Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Fresenius Kabi Product Offered
Table 82. Fresenius Kabi Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 83. Fresenius Kabi Main Business
Table 84. Fresenius Kabi Latest Developments
Table 85. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Nephron Pharmaceuticals Product Offered
Table 87. Nephron Pharmaceuticals Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 88. Nephron Pharmaceuticals Main Business
Table 89. Nephron Pharmaceuticals Latest Developments
Table 90. Nephron Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Sintetica Product Offered
Table 92. Sintetica Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 93. Sintetica Main Business
Table 94. Sintetica Latest Developments
Table 95. Sintetica Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. Akorn Product Offered
Table 97. Akorn Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 98. Akorn Main Business
Table 99. Akorn Latest Developments
Table 100. Akorn Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Zhuhai Yipin Pharmaceutical Group Product Offered
Table 102. Zhuhai Yipin Pharmaceutical Group Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 103. Zhuhai Yipin Pharmaceutical Group Main Business
Table 104. Zhuhai Yipin Pharmaceutical Group Latest Developments
Table 105. Zhuhai Yipin Pharmaceutical Group Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 106. Chengdu Tiantaishan Pharmaceutical Product Offered
Table 107. Chengdu Tiantaishan Pharmaceutical Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Chengdu Tiantaishan Pharmaceutical Main Business
Table 109. Chengdu Tiantaishan Pharmaceutical Latest Developments
Table 110. Chengdu Tiantaishan Pharmaceutical Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Qilu Pharmaceutical Product Offered
Table 112. Qilu Pharmaceutical Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 113. Qilu Pharmaceutical Main Business
Table 114. Qilu Pharmaceutical Latest Developments
Table 115. Qilu Pharmaceutical Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 116. Haisco Pharmaceutical Group Product Offered
Table 117. Haisco Pharmaceutical Group Ropivacaine Hydrochloride Injection Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 118. Haisco Pharmaceutical Group Main Business
Table 119. Haisco Pharmaceutical Group Latest Developments
Table 120. Haisco Pharmaceutical Group Basic Information, Company Total Revenue (in $ million), Ropivacaine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Ropivacaine Hydrochloride Injection
Figure 2. Ropivacaine Hydrochloride Injection Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Ropivacaine Hydrochloride Injection Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Ropivacaine Hydrochloride Injection Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 2 Mg/ml
Figure 7. Product Picture of 5 Mg/ml
Figure 8. Product Picture of 7.5 Mg/ml
Figure 9. Product Picture of 10 Mg/ml
Figure 10. Global Ropivacaine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Figure 11. Global Ropivacaine Hydrochloride Injection Value Market Share by Type (2015-2020)
Figure 12. Ropivacaine Hydrochloride Injection Consumed in Surgical Anesthesia
Figure 13. Global Ropivacaine Hydrochloride Injection Market: Surgical Anesthesia (2015-2020) (MT)
Figure 14. Global Ropivacaine Hydrochloride Injection Market: Surgical Anesthesia (2015-2020) ($ Millions)
Figure 15. Ropivacaine Hydrochloride Injection Consumed in Acute Pain Management
Figure 16. Global Ropivacaine Hydrochloride Injection Market: Acute Pain Management (2015-2020) (MT)
Figure 17. Global Ropivacaine Hydrochloride Injection Market: Acute Pain Management (2015-2020) ($ Millions)
Figure 18. Ropivacaine Hydrochloride Injection Consumed in Other
Figure 19. Global Ropivacaine Hydrochloride Injection Market: Other (2015-2020) (MT)
Figure 20. Global Ropivacaine Hydrochloride Injection Market: Other (2015-2020) ($ Millions)
Figure 21. Global Ropivacaine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Figure 22. Global Ropivacaine Hydrochloride Injection Value Market Share by Application (2015-2020)
Figure 23. Global Ropivacaine Hydrochloride Injection Sales Market Share by Company in 2017
Figure 24. Global Ropivacaine Hydrochloride Injection Sales Market Share by Company in 2019
Figure 25. Global Ropivacaine Hydrochloride Injection Revenue Market Share by Company in 2017
Figure 26. Global Ropivacaine Hydrochloride Injection Revenue Market Share by Company in 2019
Figure 27. Global Ropivacaine Hydrochloride Injection Sale Price by Company in 2019
Figure 28. Global Ropivacaine Hydrochloride Injection Consumption Market Share by Regions 2015-2020
Figure 29. Global Ropivacaine Hydrochloride Injection Value Market Share by Regions 2015-2020
Figure 30. Americas Ropivacaine Hydrochloride Injection Consumption 2015-2020 (MT)
Figure 31. Americas Ropivacaine Hydrochloride Injection Value 2015-2020 ($ Millions)
Figure 32. APAC Ropivacaine Hydrochloride Injection Consumption 2015-2020 (MT)
Figure 33. APAC Ropivacaine Hydrochloride Injection Value 2015-2020 ($ Millions)
Figure 34. Europe Ropivacaine Hydrochloride Injection Consumption 2015-2020 (MT)
Figure 35. Europe Ropivacaine Hydrochloride Injection Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption 2015-2020 (MT)
Figure 37. Middle East & Africa Ropivacaine Hydrochloride Injection Value 2015-2020 ($ Millions)
Figure 38. Americas Ropivacaine Hydrochloride Injection Consumption Market Share by Countries in 2019
Figure 39. Americas Ropivacaine Hydrochloride Injection Value Market Share by Countries in 2019
Figure 40. Americas Ropivacaine Hydrochloride Injection Consumption Market Share by Type in 2019
Figure 41. Americas Ropivacaine Hydrochloride Injection Consumption Market Share by Application in 2019
Figure 42. United States Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 43. United States Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 45. Canada Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 47. Mexico Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Ropivacaine Hydrochloride Injection Consumption Market Share by Countries in 2019
Figure 49. APAC Ropivacaine Hydrochloride Injection Value Market Share by Regions in 2019
Figure 50. APAC Ropivacaine Hydrochloride Injection Consumption Market Share by Type in 2019
Figure 51. APAC Ropivacaine Hydrochloride Injection Consumption Market Share by Application in 2019
Figure 52. China Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 53. China Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 55. Japan Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 57. Korea Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 59. Southeast Asia Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 60. India Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 61. India Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 63. Australia Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Ropivacaine Hydrochloride Injection Consumption Market Share by Countries in 2019
Figure 65. Europe Ropivacaine Hydrochloride Injection Value Market Share by Countries in 2019
Figure 66. Europe Ropivacaine Hydrochloride Injection Consumption Market Share by Type in 2019
Figure 67. Europe Ropivacaine Hydrochloride Injection Consumption Market Share by Application in 2019
Figure 68. Germany Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 69. Germany Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 70. France Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 71. France Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 72. UK Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 73. UK Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 75. Italy Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 77. Russia Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Ropivacaine Hydrochloride Injection Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption Market Share by Application in 2019
Figure 82. Egypt Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 83. Egypt Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 85. South Africa Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 87. Israel Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 89. Turkey Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Ropivacaine Hydrochloride Injection Consumption Growth 2015-2020 (MT)
Figure 91. GCC Countries Ropivacaine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 92. Global Ropivacaine Hydrochloride Injection Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 93. Global Ropivacaine Hydrochloride Injection Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 95. Americas Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 96. APAC Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 97. APAC Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 98. Europe Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 99. Europe Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 101. Middle East & Africa Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 102. United States Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 103. United States Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 104. Canada Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 105. Canada Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 106. Mexico Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 107. Mexico Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 108. Brazil Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 109. Brazil Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 110. China Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 111. China Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 112. Japan Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 113. Japan Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 114. Korea Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 115. Korea Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 117. Southeast Asia Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 118. India Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 119. India Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 120. Australia Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 121. Australia Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 122. Germany Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 123. Germany Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 124. France Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 125. France Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 126. UK Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 127. UK Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 128. Italy Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 129. Italy Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 130. Russia Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 131. Russia Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 132. Spain Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 133. Spain Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 134. Egypt Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 135. Egypt Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 136. South Africa Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 137. South Africa Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 138. Israel Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 139. Israel Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 140. Turkey Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 141. Turkey Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Ropivacaine Hydrochloride Injection Consumption 2021-2025 (MT)
Figure 143. GCC Countries Ropivacaine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 144. Pfizer Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Figure 145. Fresenius Kabi Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Figure 146. Nephron Pharmaceuticals Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Figure 147. Sintetica Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Figure 148. Akorn Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Figure 149. Zhuhai Yipin Pharmaceutical Group Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Figure 150. Chengdu Tiantaishan Pharmaceutical Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Figure 151. Qilu Pharmaceutical Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Figure 152. Haisco Pharmaceutical Group Ropivacaine Hydrochloride Injection Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets